A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Artificial intelligence (AI) improves breast cancer detection accuracy for radiologists when reading screening mammograms, ...

Revolution Medicine’s proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand prediction from Iambic.

Lunit and Microsoft are working together to push for the use of AI in cancer diagnosis. Lunit and Microsoft are working ...

SpotitEarly’s at-home breath test pairs canine scent detection with AI to deliver non-invasive, affordable early cancer ...

Artificial intelligence (AI) improves breast cancer detection accuracy for radiologists when reading screening mammograms, ...

Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Personalis, Inc. (Nasdaq: PSNL) today announced an expansion and extension of its strategic collaboration with Tempus AI, Inc ...

Personalis and Tempus AI are adding colorectal cancer as a new indication to their existing commercialization agreement.

A new AI tool, AAnet, has discovered five distinct cell types within tumors, offering a deeper look into cancer's inner ...

Coverage from “Tech Innovations in Oncology,” presented June 19, 2025, by Tennessee Oncology in Nashville, Tennessee. First ...